Enlivex Therapeutics Ltd (ENLV)

Jul 25, 2025

What drives Enlivex Therapeutics Ltd. stock priceFree Stock Market Knowledge Sharing - Autocar Professional

Jul 25, 2025

Jul 25, 2025

Enlivex Therapeutics’ (ENLV) Buy Rating Reiterated at D. Boral Capital - Defense World

Jul 25, 2025

Jul 25, 2025

Enlivex Therapeutics Ltd. Stock Analysis and ForecastFree Stock Market Query - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What makes Enlivex Therapeutics Ltd. stock price move sharplyValue Pick Scanner - Newser

Jul 25, 2025

Jul 23, 2025

Is Enlivex Therapeutics Ltd. a good long term investmentExceptional profit velocity - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Enlivex Therapeutics Ltd. stockExceptional market positioning - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Enlivex Therapeutics (ENLV) Receives Continued 'Buy' Rating from Analyst | ENLV Stock News - GuruFocus

Jul 22, 2025

Jul 16, 2025

why enlivex therapeutics ltd. stock attracts strong analyst attentionLow Risk Entry Points - Newser

Jul 16, 2025

Jul 16, 2025

Why Enlivex Therapeutics Ltd. stock attracts strong analyst attentionReal Trader Insights - beatles.ru

Jul 16, 2025

Jul 16, 2025

How Enlivex Therapeutics Ltd. stock performs during market volatilityPrecision Entry Strategy - Newser

Jul 16, 2025

Jun 17, 2025

Sepsis Market Growth to Accelerate in Forecast Period - openPR.com

Jun 17, 2025

Jun 13, 2025

Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Jeffersonian

Jun 13, 2025

Jun 13, 2025

Trust Consulting Services CEO James Radford Named One of CIO Bulletin's "Best Entrepreneurs to Watch 2025" - Marco Eagle

Jun 13, 2025

Jun 13, 2025

Unusual Machines Announces Termination of Definitive Agreement to Acquire Aloft - The Holland Sentinel

Jun 13, 2025

Jun 13, 2025

Safe 'N' Sound Environmental Services Ltd. Recognized with 2025 Consumer Choice Award for Asbestos Removal in Halton Region - Sarasota Herald-Tribune

Jun 13, 2025

Jun 11, 2025

Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025 - IndyStar

Jun 11, 2025

Jun 10, 2025

Enlivex Therapeutics (ENLV) to Present Promising Allocetra Data at EULAR Congress | ENLV Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

Enlivex Therapeutics to Present Clinical Data of Allocetra in Os - GuruFocus

Jun 10, 2025

Jun 10, 2025

Enlivex Therapeutics Ltd. to Present Allocetra™ Data at EULAR 2025 Congress in Barcelona - Nasdaq

Jun 10, 2025

Jun 10, 2025

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology - The Manila Times

Jun 10, 2025

Jun 10, 2025

Breakthrough Cell Therapy Shows Promise in Knee Osteoarthritis: Enlivex Phase I/II Trial Data at EULAR 2025 - Stock Titan

Jun 10, 2025

Jun 10, 2025

Interactive Strength Inc. (Nasdaq: TRNR) Updates FAQ's about Increasing 2025 Pro Forma Revenue Guidance to More Than $75M and Other Questions - Reno Gazette Journal

Jun 10, 2025

Jun 07, 2025

Millennium Management LLC Acquires New Holdings in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) - Defense World

Jun 07, 2025

Jun 06, 2025

Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Friday - Defense World

Jun 06, 2025

Jun 02, 2025

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform - El Paso Times

Jun 02, 2025

May 30, 2025

Enlivex Reports Q1 2025 Financial Results with Reduced Loss - TipRanks

May 30, 2025

May 29, 2025

D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering - Lohud

May 29, 2025